Vitamin K2 supplementation in haemodialysis patients: A randomized dose-finding study

Nephrology Dialysis Transplantation

Volumn 29, Issue 7, 2014, Pages 1385-1390

  Caluwé, Rogier ^a   Vandecasteele, Stefaan ^b   Van Vlem, Bruno ^a   Vermeer, Cees ^c   De Vriese, An S ^b  

^a OLV HOSPITAL   (Belgium)

^b General Hospital St Jan   (Belgium)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

haemodialysis; menaquinone; vascular calcification

Indexed keywords

MENAQ 7; MENAQUINONE; MENAQUINONE 7; PHYTOMENADIONE; PROTEIN; UNCLASSIFIED DRUG; VITAMIN K DEPENDENT MATRIX GLA PROTEIN;

ABDOMINAL DISCOMFORT; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG SAFETY; FEMALE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME; VERY ELDERLY; VITAMIN SUPPLEMENTATION;

HAEMODIALYSIS; MENAQUINONE; VASCULAR CALCIFICATION;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; CALCIUM-BINDING PROTEINS; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FOLLOW-UP STUDIES; HEMOSTATICS; HUMANS; INTERVENTION STUDIES; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RENAL DIALYSIS; SINGLE-BLIND METHOD; VASCULAR CALCIFICATION; VITAMIN K 1; VITAMIN K 2; VITAMINS; YOUNG ADULT;

EID: 84903841260     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft464     Document Type: Article

References (32)

1. Goodman WG, Goldin J, Kuizon BD et al. Coronary-Artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000.; 342: 1478-1483
2. Shroff RC, McNair R, Figg N et al. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 2008.; 118: 1748-1757
3. Blacher J, Guerin AP, Pannier B et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001.; 38: 938-942
4. London GM, Guerin AP, Marchais SJ et al. Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003.; 18: 1731-1740
5. Moe SM, Chen NX. Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol 2008.; 19: 213-216
6. Schoppet m, shroff rc, hofbauer lc et al.Exploring the biology of vascular calcification in chronic kidney disease: What's circulating? Kidney Int 2008.; 73: 384-390
7. Hur DJ, Raymond GV, Kahler SG et al. A novel MGP mutation in a consanguineous family: Review of the clinical and molecular characteristics of Keutel syndrome. Am J Med Genet A 2005.; 135: 36-40
8. Luo G, Ducy P, McKee MD et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix Gla protein. Nature 1997.; 386: 78-81
9. Price PA, Faus SA, Williamson MK. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 1998.; 18: 1400-1407
10. Bostrom K, Tsao D, Shen S et al. Matrix Gla protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells. J Biol Chem 2001.; 276: 14044-14052
11. Cranenburg EC, Koos R, Schurgers LJ et al. Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species. Thromb Haemost 2010.; 104: 811-822
12. Murshed M, Schinke T, McKee MD et al. Extracellular matrix mineralization is regulated locally.; different roles of two gla-containing proteins. J Cell Biol 2004.; 165: 625-630
13. Schurgers LJ, Cranenburg EC, Vermeer C. Matrix Gla-protein: The calcification inhibitor in need of vitamin K. Thromb Haemost 2008.; 100: 593-603
14. Schurgers LJ, Barreto DV, Barreto FC et al. The circulating inactive form of matrix Gla protein is a surrogate marker for vascular calcification in chronic kidney disease: A preliminary report. Clin J Am Soc Nephrol 2010.; 5: 568-575
15. Cranenburg EC, Schurgers LJ, Uiterwijk HH et al. Vitamin K intake and status are low in hemodialysis patients. Kidney Int 2012.; 82: 605-610
16. Pilkey RM, Morton AR, Boffa MB et al. Subclinical vitamin K deficiency in hemodialysis patients. Am J Kidney Dis 2007.; 49: 432-439
17. Schurgers LJ, Vermeer C. Determination of phylloquinone and menaquinones in food. Effect of food matrix on circulating vitamin K concentrations. Haemostasis 2000.; 30: 298-307
18. Westenfeld R, Krueger T, Schlieper G et al. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: A randomized trial. Am J Kidney Dis 2012.; 59: 186-195
19. Schurgers LJ, Vermeer C. Differential lipoprotein transport pathways of K-vitamins in healthy subjects. Biochim Biophys Acta 2002.; 1570: 27-32
20. Buitenhuis HC, Soute BA, Vermeer C. Comparison of the vitamins K1, K2 and K3 as cofactors for the hepatic vitamin K-dependent carboxylase. Biochim Biophys Acta 1990.; 1034: 170-175
21. Souci S, Fachmann W, Kraut H. Die Zusammensetzung der Lebensmittel. Stuttgart:Wissenschaftliche Verlagsgesellschaft, 2013 Nutrient Data Laboratory, food composition. http://www.nal.usda.gov/ fnic/foodcomp/cgi-bin/list. 2013
22. Beulens JW, Booth SL, van den Heuvel EG et al. The role of menaquinones (vitamin K2) in human health. Br J Nutr 2013.; 110: 1357-1368
23. Schurgers LJ, Geleijnse JM, Grobbee DE et al. Nutritional intake of vitamins K-1 (phylloquinone) and K-2 (menaquinone) in The Netherlands. J Nutr Environ Med 1999.; 9: 115-122
24. Malyszko J, Wolczynski S, Skrzydlewska E et al. Vitamin K status in relation to bone metabolism in patients with renal failure. Am J Nephrol 2002.; 22: 504-508
25. Geleijnse JM, Vermeer C, Grobbee DE et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: The Rotterdam Study. J Nutr 2004.; 134: 3100-3105
26. Gast GC, de Roos NM, Sluijs I et al. A high menaquinone intake reduces the incidence of coronary heart disease. Nutr Metab Cardiovasc Dis 2009.; 19: 504-510
27. Beulens JW, Bots ML, Atsma F et al. High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis 2009.; 203: 489-493
28. Braam LA, Hoeks AP, Brouns F et al. Beneficial effects of vitamins D and K on the elastic properties of the vessel wall in postmenopausal women: A follow-up study. Thromb Haemost 2004.; 91: 373-380
29. Shea MK, O'Donnell CJ, Hoffmann U et al. Vitamin K supplementation and progression of coronary artery calcium in older men and women. Am J Clin Nutr 2009.; 89: 1799-1807
30. Ronden JE, Drittij-Reijnders MJ, Vermeer C et al. Intestinal flora is not an intermediate in the phylloquinone-menaquinone-4 conversion in the rat. Biochim Biophys Acta 1998.; 1379: 69-75
31. Davidson RT, Foley AL, Engelke JA et al. Conversion of dietary phylloquinone to tissue menaquinone-4 in rats is not dependent on gut bacteria. J Nutr 1998.; 128: 220-223
32. Thijssen HH, Vervoort LM, Schurgers LJ et al. Menadione is a metabolite of oral vitamin K. Br J Nutr 2006.; 95: 260-266